Kimia Biosciences Limited (BOM:530313)
27.92
+0.74 (2.72%)
At close: Aug 21, 2026
Kimia Biosciences Market Cap
Kimia Biosciences has a market cap or net worth of 1.32 billion as of August 21, 2026. Its market cap has decreased by -30.17% in one year.
Market Cap
1.32B
Enterprise Value
1.66B
Revenue
1.12B
Ranking
n/a
PE Ratio
17.42
Stock Price
27.92
ChartMarket Cap Chart
Since May 17, 2016, Kimia Biosciences's market cap has increased from 68.68M to 1.32B, an increase of 1,823.36%. That is a compound annual growth rate of 33.37%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 1.32B | -17.76% |
| Dec 31, 2025 | 1.61B | -25.63% |
| Dec 31, 2024 | 2.16B | 24.05% |
| Dec 29, 2023 | 1.74B | -14.42% |
| Dec 30, 2022 | 2.03B | -30.19% |
| Dec 31, 2021 | 2.91B | 33.33% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aarey Drugs & Pharmaceuticals | 2.32B |
| Resonance Specialties | 2.05B |
| Accretion Nutraveda | 2.03B |
| Panchsheel Organics | 1.60B |
| Auro Laboratories | 1.46B |
| Smruthi Organics | 1.45B |
| Krebs Biochemicals & Industries | 1.17B |
| Tyche Industries | 1.07B |